Table 3.

Changes in the cell surface antigen expression between HD and UT, and UT and IFNβ-treated subjects

Markers	HD vs. UT				UT vs. IFNβ
	DN		CD8hi		DN		CD8hi
	Differencea	Signifiancec	Differencea	Signifiancec	Differenceb	Signifiancec	Differenceb	Signifiancec
CCR5	0.29	****	0.27	***	−0.08	ns	−0.05	ns
CCR6	0.55	***	0.73	***	−0.44	****	−0.34	***
CD28	0.05	ns	0.14	*	0.02	ns	−0.05	*
CD45RO	−0.39	**	−0.45	**	−0.09	ns	0.02	ns
CD49d	0.06	ns	0.00	ns	−0.10	*	−0.13	*
CD95	0.18	***	0.27	***	0.02	ns	0.00	ns
CD107a	0.10	ns	0.04	ns	−0.01	ns	0.16	*
CD127	0.20	**	0.09	*	0.00	ns	−0.09	*
CD150	0.33	**	0.27	*	−0.10	ns	0.02	ns
CD279	nd	–	0.00	ns	nd	–	0.22	**
ICOS	0.09	ns	0.06	ns	0.12	*	0.06	*
NKG2D	0.05	ns	0.04	ns	−0.32	*	−0.20	ns

^a $log10\frac{\text{median}\text{MFI}\text{for}\text{HD}}{\text{median}\text{MFI}\text{for}\text{UT}}$

^b $log10\frac{\text{median}\text{MFI}\text{for}\text{UT}}{\text{median}\text{MFI}\text{for}\text{IFN}\mathit{\beta }}$

^cStatistical significances are shown with asterisks (*P < 0.05; **P < 0.01; ***P < 0.001) and ns not significant